Vitamin D supplementation modulates t cell-mediated immunity in humans: Results from a randomized control trial

Journal of Clinical Endocrinology and Metabolism

Volumn 101, Issue 2, 2016, Pages 533-538

  Konijeti, Gauree Gupta ^a,b,c   Arora, Pankaj ^d   Boylan, Matthew R ^c   Song, Yanna ^e   Huang, Shi ^e   Harrell, Frank ^e   Newton Cheh, Christopher ^c   O'Neill, DIllon ^e   Korzenik, Joshua ^a   Wang, Thomas J ^e   Chan, Andrew T ^c,f  

^a SCRIPPS CLINIC   (United States)

^b SCRIPPS TRANSLATIONAL SCIENCE INSTITUTE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e VANDERBILT UNIVERSITY   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIFEDIOL; COLECALCIFEROL; VITAMIN;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; FEMALE; HUMAN; HUMAN CELL; HYPERTENSION; LOW DRUG DOSE; MALE; MULTICENTER STUDY; NUCLEIC ACID SYNTHESIS; PRIORITY JOURNAL; RACE; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; T LYMPHOCYTE ACTIVATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; BLOOD; CLINICAL TRIAL; COHORT ANALYSIS; DIETARY SUPPLEMENT; DRUG EFFECTS; FOLLOW UP; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MIDDLE AGED; T LYMPHOCYTE;

ADENOSINE TRIPHOSPHATE; ADULT; CHOLECALCIFEROL; COHORT STUDIES; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; T-LYMPHOCYTES; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84959340171     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-3599     Document Type: Article

References (24)

1. Ananthakrishnan AN, Khalili H, Higuchi LM, et al. Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology. 2012;142:482-489.
2. Hayes CE, Hubler SL, Moore JR, Barta LE, Praska CE, Nashold FE. Vitamin D actions on CD4() T cells in autoimmune disease. Front Immunol. 2015;6:100.
3. White JH. Vitamin D metabolism and signaling in the immune system. Rev Endocrine Metab Disorders. 2012;13:21-29.
4. Yang CY, Leung PS, Adamopoulos IE, Gershwin ME. The implication of vitamin D and autoimmunity: a comprehensive review. Clin Rev AllergyI Immunol. 2013;45:217-226.
5. Muscogiuri G, Tirabassi G, Bizzaro G, et al. Vitamin D and thyroid disease: to D or not to D? Eur J Clin Nutr. 2015;69:291-296.
6. Herold KC, Vignali DA, Cooke A, Bluestone JA. Type 1 diabetes: translating mechanistic observations into effective clinical outcomes. Nat Rev Immunol. 2013;13:243-256.
7. Gabbay MA, Sato MN, Finazzo C, Duarte AJ, Dib SA. Effect of cholecalciferol as adjunctive therapy with insulin on protective immunologic profile and decline of residual beta α-Cell function in newonset type 1 diabetes mellitus. Arch Pediatr Adolesc Med. 2012; 166:601-607.
8. Raftery T, Merrick M, Healy M, et al. VitaminDstatus is associated with intestinal inflammation as measured by fecal calprotectin in Crohn's disease in clinical remission. Dig Dis Sci. 2015;60:2427-2435.
9. Ananthakrishnan AN, Cagan A, Gainer VS, et al. Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn's disease. Inflamm Bowel Dise. 2013;19:1921-1927.
10. Ananthakrishnan AN, Cagan A, Gainer VS, et al. Higher plasma vitamin D is associated with reduced risk of Clostridium difficile infection in patients with inflammatory bowel diseases. Alim Pharmacol Therapeutics. 2014;39:1136-1142.
11. Ananthakrishnan AN, Cheng SC, Cai T, et al. Association between reduced plasma 25-hydroxy vitamin D and increased risk of cancer in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2014;12:821-827.
12. Mokry LE, Ross S, Ahmad OS, et al. Vitamin D and risk of multiple sclerosis: a Mendelian randomization study. PLoS Med. 2015;12: e1001866.
13. Soilu-Hanninen M, Aivo J, Lindstrom BM, et al. A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon beta-1b in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2012;83:565-571.
14. Allen AC, Kelly S, Basdeo SA, et al. A pilot study of the immunological effects of high-dose vitaminDin healthy volunteers. Multiple Scler. 2012;18:1797-1800.
15. Kimball S, Vieth R, Dosch HM, et al. Cholecalciferol plus calcium suppresses abnormalPBMCreactivity in patients with multiple sclerosis. J Clin Endocrinol Metab. 2011;96:2826-2834.
16. Bock G, Prietl B, Mader JK, et al. The effect of vitamin D supplementation on peripheral regulatory T cells and beta cell function in healthy humans: a randomized controlled trial. Diabetes Metab Res Rev. 2011;27:942-945.
17. Arora P, Song Y, Dusek J, et al. Vitamin D therapy in individuals with prehypertension or hypertension: the DAYLIGHT trial. Circulation. 2015;131:254-262.
18. Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O'Garra A. 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4()Tcells to enhance the development of Th2 cells. J Immunol. 2001;167:4974-4980.
19. Mora JR, IwataM,von AndrianUH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol. 2008;8:685-698.
20. Kongsbak M, von Essen MR, BoDing L, et al. Vitamin D up-regulates the vitamin D receptor by protecting it from proteasomal degradation in human CD4 T cells. PloS One. 2014;9:e96695.
21. von Essen MR, Kongsbak M, Schjerling P, Olgaard K, Odum N, Geisler C. Vitamin D controls T cell antigen receptor signaling and activation of human T cells. NatI Immunol. 2010;11:344-349.
22. Jorgensen SP, Agnholt J, Glerup H, et al. Clinical trial: vitamin D3 treatment in Crohn's disease-a randomized double-blind placebocontrolled study. Alim Pharmacol Therapeutics. 2010;32:377-383.
23. Kampman MT, Steffensen LH, Mellgren SI, Jorgensen L. Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial. Multiple Scler. 2012;18:1144-1151.
24. Sanchez-Velasco P, Rodrigo E, Valero R, et al. Intracellular ATP concentrations of CD4 cells in kidney transplant patients with and without infection. Clin Transplant. 2008;22:55-60.